Gross D W, Donat J R, Boyle C A
Department of Medicine, University of Saskatchewan, Saskatoon, Canada.
Headache. 1995 Nov-Dec;35(10):637-8. doi: 10.1111/j.1526-4610.1995.hed3510637.x.
Dihydroergotamine and metoclopramide have been used in the treatment of benign headache for many years. The presumed mechanism of action of dihydroergotamine and metoclopramide is related to these drugs' affinity for serotonergic receptors. We present three cases of the use of dihydroergotamine and metoclopramide in patients with organic headache (two patients with viral meningitis and one patient with meningeal carcinomatosis). All three patients had excellent symptomatic relief. Our results demonstrate that dihydroergotamine and metoclopramide can be effective in treating organic headache and, therefore, symptomatic relief can not be assumed to signify benign disease.
多年来,双氢麦角胺和甲氧氯普胺一直用于治疗良性头痛。双氢麦角胺和甲氧氯普胺的推测作用机制与这些药物对血清素能受体的亲和力有关。我们报告了3例使用双氢麦角胺和甲氧氯普胺治疗器质性头痛患者的病例(2例病毒性脑膜炎患者和1例脑膜癌病患者)。所有3例患者的症状均得到显著缓解。我们的结果表明,双氢麦角胺和甲氧氯普胺可有效治疗器质性头痛,因此,不能认为症状缓解就意味着是良性疾病。